Prior to the development of nitisinone, dietary restrictions and liver transplantation were the only forms of treatment for HT1. A study regarding the efficacy of treatment with nitisinone and dietary restrictions found that 93% of people survived at two years, four years, and six years indicating the prognosis of stabilizing the HT1 disease state is positive.
Tyrosinemia type I
Aspartylglucosaminuria
Hawkinsinuria
Aldolase A deficiency
Essential fructosuria
Transaldolase deficiency
Phenylketonuria
Cystathioninuria